PDF herunterladen
CC BY-NC-ND 4.0 · Eur J Dent 2015; 09(01): 047-052
DOI: 10.4103/1305-7456.149640
Original Article
Dental Investigation Society

The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India

Neelkant Patil
1   Department of Oral Medicine, Vyas Dental College, Jodhpur, Rajasthan, India
,
Vishwajit Rampratap Chaurasia
2   Department of Conservative Dentistry and Endodontics, KLE Dental College, Belgaum, Karnataka, India
,
Prashant Babaji
3   Department of Pedodontics, Vyas Dental College, Jodhpur, Rajasthan, India
,
Dnsv Ramesh
4   Department of Oral Medicine and Radiology, AME'S Dental College and Hospital, Raichur, Karnataka, India
,
Kshitij Jhamb
5   Department of Oral and Maxillofacial Surgery, Indraprasthaal College, Haryana, India
,
Akanksha Manmohan Sharma
6   BDS Student, KLE Dental College, Belgaum, Karnataka, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. September 2019 (online)

Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

ABSTRACT

Objectives: Acquired Immunodeficiency Syndrome (AIDS) is a highly lethal, progressively epidemic viral infection characterized by profound impairment of the immune system. Oral manifestations are common in Human Immunodeficiency Virus (HIV) infected AIDS patients, and are usually the first indicator of symptom and disease progression. The main objective of the current study was to compare the prevalence of oral manifestations in HIV patients on Highly Active Antiretroviral Therapy (HAART) with those, not on HAART therapies. Materials and Methods: A cross sectional study was conducted among 100 patients diagnosed as human immune virus sero-positive. These patients were divided equally into two groups (50 each); Group I patients on HAART and Group II patients who were not on HAART. Information regarding age, sex and cluster of differentiation 4 cell count was obtained from the medical records. Oral examination was done, and findings were recorded by using internationally accepted presumptive clinical criteria. Statistical analysis was performed using Chi-square statistical test. Results: The presence of oral manifestations was significantly decreased in subjects on HAART (32%) compared to those who are not on HAART (56%). The most common oral lesions detected in patients on HAART were increased oral hyper-pigmentation (14%), recurrent aphthous stomatitis (8%), non-specific ulcerations (4%), pseudo-membranous candidiasis (2%), periodontitis (2%) and xerostomia (2%), whereas in non HAART oral hyperpigmentation (10%), pseudo-membranous candidiasis (8%), angular cheilitis (4%), and erythematous candidiasis (4%) and Periodontitis (14%) were more prevalent. Conclusion: The number and severity of oral manifestation decreased, and even there was a change in the type of oral manifestations on HAART, which may be because of the improvement in immunity gained by the therapy.

Key words:

Cluster of differentiation 4 cell - highly active antiretroviral therapy - immunodeficiency virus/acquired immunodeficiency syndrome - oral manifestations
 

  • REFERENCES

  • 1 Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci 2011; 53: 203-11
    CrossrefPubMedGoogle Scholar
  • 2 Shrimali L. A study of oral manifestation of HIV/AIDS. Int J Oral Maxillofac Path 2010; 1: 8-12
    Google Scholar
  • 3 AIDS. Available from: http://www.aids.gov/federal-resources/around-the-world/global-aids-overview [Last assessed on 2014 May 14]
  • 4 Gaurav S, Keerthilatha PM, Archna N. Prevalence of oral manifestations and their association with CD4/CD8 ratio and HIV viral load in South India. Int J Dent 2011; 2011: 964278
    PubMedGoogle Scholar
  • 5 Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman R. et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis 1993; 17: 802-10
    CrossrefGoogle Scholar
  • 6 Ghate MV, Mehendale SM, Mahajan BA, Yadav R, Brahme RG, Divekar AD. et al. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India. Natl Med J India 2000; 13: 183-7
    PubMedGoogle Scholar
  • 7 Hoffmann C, Kamps BS. HIV Medicine. 2003. Paris: Flying Publisher; 2003: p. 15-8
    Google Scholar
  • 8 Umadevi KM, Ranganathan K, Pavithra S, Hemalatha R, Saraswathi TR, Kumarasamy N. et al. Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India. J Oral Pathol Med 2007; 36: 136-41
    CrossrefPubMedGoogle Scholar
  • 9 Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 623-8
    CrossrefPubMedGoogle Scholar
  • 10 Annapurna CS, Prince CN, Sivaraj S, Ali IM. Oral manifestations of HIV patients in South Indian population. J Pharm Bioallied Sci 2012; 4: S364-8
    CrossrefPubMedGoogle Scholar
  • 11 Adebola AR, Adeleke SI, Mukhtar M, Osunde OD, Akhiwu BI, Ladeinde A. Oral manifestation of HIV/AIDS infections in paediatric Nigerian patients. Niger Med J 2012; 53: 150-4
    CrossrefPubMedGoogle Scholar
  • 12 Eweka OM, Agbelusi GA, Odukoya O. Prevalence of oral lesions and the effects of HAART in adult HIV patients attending a tertiary hospital in Lagos, Nigeria. Open J Stomatol 2012; 2: 200-5
    Google Scholar
  • 13 Kroidl A, Schaeben A, Oette M, Wettstein M, Herfordt A, Häussinger D. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur J Med Res 2005; 10: 448-53
    PubMedGoogle Scholar
  • 14 Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006; 19: 57-62
    CrossrefPubMedGoogle Scholar
  • 15 Hamza OJ, Matee MI, Simon EN, Kikwilu E, Moshi MJ, Mugusi F. et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006; 6: 12
    CrossrefPubMedGoogle Scholar
  • 16 Taiwo OO, Hassan Z. The impact of highly active antiretroviral therapy (HAART) on the clinical features of HIV-related oral lesions in Nigeria. AIDS Res Ther 2010; 7: 19
    CrossrefPubMedGoogle Scholar
  • 17 Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12: 537-42
    CrossrefPubMedGoogle Scholar
  • 18 Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000; 6: 152-7
    PubMedGoogle Scholar
  • 19 Ranganathan K, Geethalakshmi E, Krishna MohanRao U, Vidya KM, Kumarasamy N, Solomon S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. Int J Paediatr Dent 2010; 20: 276-82
    Google Scholar
  • 20 Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul P, Nilmanat A. et al. Effects of long-term use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 2010; 39: 397-406
    PubMedGoogle Scholar
  • 21 Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol 2004; 70: 82-6
    PubMedGoogle Scholar
  • 22 Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. J Oral Pathol Med 2002; 31: 169-74
    CrossrefPubMedGoogle Scholar
  • 23 Nawaz T, Narain JP. Emanuele pontal. The Use of Antiretroviral Therapy: A Simplified Approach for Resource-Constrained Countries. Sea-AIDS New Delhi, India: WHO-Searo; 2002: p. 133
    Google Scholar